DSpace at RU >

Browsing by Author Schellens, J.H.M.

Full Text	Issue Date	Title	Author(s)
	2008	The Dutch model for clinical pharmacology: collaboration between physician- and pharmacist--clinical pharmacologists.	Schellens, J.H.M.; Grouls, R.; Guchelaar, H.J.; Touw, D.J.; Rongen, G.A.P.J.M., et al
	2008	Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor.	Hoebers, F.J.; Pluim, D.; Hart, A.A.M.; Verheij, M.; Balm, A.J.M., et al
	2008	Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.	Gast, M.C.; Tinteren, H van; Bontenbal, M.; Hoesel, R.Q. van; Nooij, M.A., et al
	2006	Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel	Bosch, T.M.; Huitema, A.D.; Doodeman, V.D.; Jansen, R.; Witteveen, E., et al
	2006	Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).	Hoebers, F.J.; Pluim, D.; Verheij, M.; Balm, A.J.M.; Bartelink, H., et al
	2006	Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.	Vink, S.R.; Lagerwerf, S.; Mesman, E.; Schellens, J.H.M.; Begg, A.C., et al
	2005	Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam.	Kesteren, C. van; Zandvliet, A.S.; Karlsson, M.O.; Mathôt, R.A.A.; Punt, C.J.A., et al
	2005	Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides.	Sesink, A.L.; Arts, I.C.; Boer, V.C. de; Breedveld, P.; Schellens, J.H.M., et al
	2005	[Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression]	Lekkerkerker, J.F.F.; Schobben, A.F.; Dissel, J.T. van; Hekster, Y.A.; Hoes, A.W., et al